PRODUCT INFORMATION FOR THE USER
Rectogesic 4 mg/g Rectal Ointment
Glyceryl Trinitrate
Read this entire leaflet carefully before you start using this medicine, because it contains important information for you.
1. What Rectogesic is and what it is used for
2. What you need to know before using Rectogesic
3. How to use Rectogesic
4. Possible side effects
5. Storage of Rectogesic
6. Contents of the pack and additional information
RECTOGESIC is a rectal ointment that contains as its active ingredient glyceryl trinitrate. Glyceryl trinitrate belongs to a group of drugs known as organic nitrates.
The ointment will help to relieve painful symptoms caused by chronic anal fissures. An anal fissure is a tear in the skin that covers the anal canal. The topical application of glyceryl trinitrate to the anal canal reduces anal pressure and increases blood flow, which reduces the sensation of pain.
Do not use Rectogesic:
Be especially careful with Rectogesic:
Rectogesic may lower blood pressure. When getting up from a lying or sitting position, do so slowly to avoid dizziness. It is more likely to lower blood pressure if you drink alcohol during treatment with Rectogesic.
Children and adolescents
Rectogesic is not suitable for children and adolescents under 18 years old as it has not been evaluated in patients of this age group.
Use of Rectogesic with other medicines
Inform your doctor or pharmacist if you are using or have recently used other medicines, including those purchased without a prescription.
The following medicines may increase the effect of Rectogesic to lower blood pressure:
Other medicines
Use of Rectogesic with alcohol
Be careful with alcohol consumption as the cream may have a greater effect than usual.
Pregnancy and breastfeeding
You should not use Rectogesic during pregnancy or breastfeeding.
Consult your doctor or pharmacist before using a medicine during pregnancy or breastfeeding.
Driving and operating machinery
No studies have been conducted on the ability to drive and operate machinery with Rectal Cream Rectogesic 4 mg/g. If you start to feel dizzy or sleepy or have blurred vision when you start using the cream, do not drive or operate machinery until these effects have disappeared.
Rectogesic contains lanolin and propylene glycol
This medicine contains lanolin (wool fat), which may cause local skin reactions (such as contact dermatitis). This medicine also contains propylene glycol, which may cause skin irritation.
Administration Method
Rectal Rectogesic 4 mg/g Ointment is for rectal use.
Follow exactly the administration instructions for this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. The recommended dose is approximately 375 mg of ointment (approximately 1.5 mg of glyceryl trinitrate) applied to the anal canal every 12 hours.
The finger can be covered with plastic film or a finger cot before applying the ointment. Finger cots can be obtained from your local pharmacy or a surgical supply provider and plastic film from a local store. The covered finger is placed next to the 2.5 cm dosing line, which appears on the outer packaging, and a quantity of ointment equivalent to the length of the line is taken from the tube with a light pressure. Insert the ointment gently into the anal canal with your finger. The finger with ointment must be inserted up to the first knuckle (approximately 1 cm) inside the anus.
Apply the ointment every 12 hours as instructed by your doctor and do not exceed the indicated dose. Wash your hands after each use and dispose of the finger cot or plastic film (not down the toilet).
Treatment may be continued until the pain disappears, or for a maximum of 8 weeks. If the pain does not subside after using Rectogesic, you should consult your doctor again to rule out another cause of pain.
If you use more Rectogesic than you should
If you use a quantity of ointment greater than indicated, you may feel dizzy or lightheaded. You may also feel a rapid heart rate or palpitations. If you experience these symptoms, clean off the excess and speak immediately with your doctor or pharmacist.
If you forgot to use Rectogesic
Do not apply a double dose to compensate for missed doses. Apply the next dose at the usual time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
Severe side effects:
Other side effects:
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1000 people)
Side effects of unknown frequency (frequency cannot be estimated from available data)
Other known side effects associated with glyceryl trinitrate products (unknown frequency)
Reporting side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this prospectus. You can also report them directly through the Spanish System for Pharmacovigilance of Medicinal Products for Human Use: https://www.notificaRAM.es.
By reporting side effects, you can contribute to providing more information about the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the tube and the box after CAD. The expiration date is the last day of the month indicated.
Once opened, use the ointment within the next 8 weeks.
The active ingredient is glyceryl trinitrate. One gram of rectal ointment contains 4 mg of glyceryl trinitrate. The normal dose of 375 mg of Rectogesic contains approximately 1.5 mg of glyceryl trinitrate.
The other components (excipients) are: propylene glycol, lanolin, sorbitan sesquioleate, hard white paraffin, and soft white paraffin.
Appearance of Rectogesic and packaging size
Rectogesic is a translucent, smooth, and white rectal ointment formulation supplied in 30 g aluminum tubes.
Holder of the marketing authorization and Responsible for manufacturing.
Holder of the Marketing Authorization
Grünenthal Pharma, S.A.
Doctor Zamenhof, 36
28027 Madrid
Spain
Responsible for manufacturing
PHARBIL Waltrop GmbH
Im Wirrigen 25
45731 Waltrop
Germany
Last review date of this leaflet:May 2015
The detailed and updated information on this medicine is available on the website of the Spanish Agency of Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.